1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow RP2: new trials by email Literature Review of RP2 trials Research Report on RP2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors RP2, nivolumab - Cancer | Phase 1 | Active not recruiting | Replimune, Inc. | 36 | 2019-10-17 | 2026-02-27 |
Breast Neoplasms (1) · Gastrointestinal Neoplasms (1) · Lung Neoplasms (1) · Neoplasms (1) · Uveal Melanoma (1)
Replimune, Inc. (1)
Spain (1) · United Kingdom (1)
Gary Vanasse, MD (1)